Vanguard Portfolio Management’s Ginkgo Bioworks DNA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$18.7M Buy
1,457,573
+519,770
+55% +$4.23M ﹤0.01% 1975
2026
Q2
$9.29M Buy
937,803
+372,151
+66% +$3.11M ﹤0.01% 2219
2026
Q1
$3.47M Buy
+565,652
New +$4.71M ﹤0.01% 2436

Other funds holding DNA

Vanguard Portfolio Management's DNA Position: Q3 2026 in Review

Vanguard Portfolio Management increased its Ginkgo Bioworks (DNA) stake by 55% in Q3 2026, buying an estimated $4.23M and bringing the position to 1,457,573 shares worth $18.7M. The position accounts for ﹤0.01% of the portfolio, ranked #1975.

Vanguard Portfolio Management first reported a position in DNA in Q1 2026 and has held it in 3 quarters since. 185 funds tracked by Wall St. Rank hold DNA as of Q3 2026.

  • Vanguard Portfolio Management held 1,457,573 shares of Ginkgo Bioworks worth $18.7M as of Q3 2026.
  • Vanguard Portfolio Management bought 519,770 Ginkgo Bioworks shares in Q3 2026, an estimated $4.23M.
  • Ginkgo Bioworks made up ﹤0.01% of Vanguard Portfolio Management's portfolio in Q3 2026, its #1975 holding.
  • Vanguard Portfolio Management first reported a position in Ginkgo Bioworks in Q1 2026 and has held it in 3 quarters since.
  • 185 funds tracked by Wall St. Rank held Ginkgo Bioworks as of Q3 2026.

Based on Vanguard Portfolio Management's 13F filing for Q3 2026, filed 13 Nov 2026.